Inventor · disambiguated record
Edna Cukierman
Also filed as: CUKIERMAN EDNA
2 granted patents·5 pending applications·32 citations·filing 2001–2025
55Inventor score
Files withINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER5INSTITUTE FOR CANCER RES1US HEALTH1
Top patents by PatentIndex Score
7 records- 0185US6743626B2Artificial salivary glandUS HEALTH·Filed 2001·Granted Jun 1, 2004·32 cites·1 claims
- 0255US2024122922A1Methods Of Treating Cancer With Transmembrane Protein 16F (TMEM16F) InhibitorsINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2023·Application pending·0 cites
- 0342US2019249215A1Three-Dimensional Cell-Derived Extracellular Matrix/Gel SystemsINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2019·Application pending·0 cites
- 0441US12098193B2Netrin G1 as a biomarker for enhancing tumor treatment efficacyINSTITUTE FOR CANCER RES·Filed 2018·Granted Sep 24, 2024·0 cites·4 claims
- 0539US2025312336A1Compositions And Methods For Treating Cancer With Calcium Channel InhibitorsINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2025·Application pending·0 cites
- 0633US2022289823A1Netrin G1 And Netrin G1 Ligand Peptides And Antibodies And Uses ThereofINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2020·Application pending·0 cites
- 0724US2023152325A1Active Alpha-5-Beta-1 Integrin As A Biomarker For Enhancing Tumor Treatment EfficacyINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →